Trials / Completed
CompletedNCT06006754
Influence of Enteral Microbiome on Mortality of Patients With Cardiogenic Shock
Influence of Enteral Microbiome Composition and Microbiome Dependent Metabolites on Mortality of Patients With Cardiogenic Shock
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 40 (actual)
- Sponsor
- University Hospital, Essen · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Cardiogenic shock is associated with a high mortality. The microbiome is a double-edged sword which can convey protective and detrimental cardiovascular effects. The significance of the enteral micobiome on cardiovascular mortality of patients with cardiogenic shock is still not known. This study aims to provide a deeper understanding of the role of the enteral microbiome and microbiome dependent metabolites in mortality and disease progression of patients with cardiogenic shock.
Conditions
- Cardiogenic Shock
- Microbial Colonization
- Out-Of-Hospital Cardiac Arrest
- Acute Heart Failure
- Acute Myocardial Infarction
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Observational study | No intervention: observational study |
Timeline
- Start date
- 2023-08-30
- Primary completion
- 2024-08-15
- Completion
- 2025-02-15
- First posted
- 2023-08-23
- Last updated
- 2025-08-24
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT06006754. Inclusion in this directory is not an endorsement.